InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: atptx post# 264621

Sunday, 05/22/2016 8:40:27 AM

Sunday, May 22, 2016 8:40:27 AM

Post# of 346002
thanks and many glycoproteins, such as Tim1/Tim4...etc..etc... bind Phosphatidylserine

Targeting PS at the surface will be required and AstraZeneca vetted PS Targeting and how fast will they move forward

A few trials to dozens of trials to hundreds of trials....hmmmm


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News